Copyright
©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Nov 7, 2023; 29(41): 5683-5698
Published online Nov 7, 2023. doi: 10.3748/wjg.v29.i41.5683
Published online Nov 7, 2023. doi: 10.3748/wjg.v29.i41.5683
First report on establishment and characterization of the extrahepatic cholangiocarcinoma sarcoma cell line CBC2T-2
Ning-Zu Jiang, Ming-Zhen Bai, Chong-Fei Huang, Ze-Long Ma, Ru-Yang Zhong, Wen-Kang Fu, Long Gao, Liang Tian, Ning-Ning Mi, Hai-Dong Ma, Ya-Wen Lu, Zi-Ang Zhang, Jin-Yu Zhao, Hai-Ying Yu, Bao-Ping Zhang, Xian-Zhuo Zhang, Yan-Xian Ren, Chao Zhang, Yong Zhang, Ping Yue, Yan-Yan Lin, The First Clinical Medical College, Lanzhou University, Lanzhou 730000, Gansu Province, China
Ning-Zu Jiang, Ming-Zhen Bai, Chong-Fei Huang, Ze-Long Ma, Ru-Yang Zhong, Wen-Kang Fu, Long Gao, Liang Tian, Ning-Ning Mi, Hai-Dong Ma, Ya-Wen Lu, Zi-Ang Zhang, Jin-Yu Zhao, Hai-Ying Yu, Bao-Ping Zhang, Xian-Zhuo Zhang, Yan-Xian Ren, Chao Zhang, Yong Zhang, Ping Yue, Yan-Yan Lin, Department of General Surgery, The First Hospital of Lanzhou University, Lanzhou 730000, Gansu Province, China
Ning-Zu Jiang, Ming-Zhen Bai, Chong-Fei Huang, Ze-Long Ma, Ru-Yang Zhong, Wen-Kang Fu, Long Gao, Liang Tian, Ning-Ning Mi, Hai-Dong Ma, Ya-Wen Lu, Zi-Ang Zhang, Jin-Yu Zhao, Hai-Ying Yu, Bao-Ping Zhang, Xian-Zhuo Zhang, Yan-Xian Ren, Chao Zhang, Yong Zhang, Ping Yue, Yan-Yan Lin, Laboratory of Biological Therapy and Regenerative Medicine Transformation Gansu Province, The First Hospital of Lanzhou University, Lanzhou 730000, Gansu Province, China
Wen-Bo Meng, Department of General Surgery, The First Hospital of Lanzhou University and Laboratory of Biological Therapy and Regenerative Medicine Transformation Gansu Province, Lanzhou 730000, Gansu Province, China
Author contributions: Jiang NZ and Ren YX interpreted the study design; Bai MZ and Gao L supervised our study; Yue P, Lin YY, and Meng WB obtained the research fund; Huang CF, Ma ZL, and Mi NN screened the publications, performed statistics, and drafted the manuscript; Ma HD and Lu YW helped perform statistics; Fu WK, Tian L, Zhao JY, Zhang BP, Zhang XZ, Zhang C, and Zhang Y revised the manuscript; and all authors contributed to the article and approved the submitted version.
Supported by the National Natural Science Foundation of China , No. 82060551 ; and Lanzhou Chengguan District Science and Technology Planning Project , No. 2019JSCX0092 .
Institutional review board statement: This study was approved by the Ethics Committee of the First Hospital of Lanzhou University (LDYYLL-2022-489) and informed consent was obtained from all the patients. This study adhered to the 1964 Declaration of Helsinki and its subsequent amendments and similar ethical standards.
Institutional animal care and use committee statement: All procedures involving animals were reviewed and approved by the Institutional Animal Care and Use Committee of the First Hospital of Lanzhou University.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Data sharing statement: The datasets used and/or analysed during the current study are available from the corresponding author upon reasonable request.
ARRIVE guidelines statement: The authors have read the ARRIVE guidelines, and the manuscript was prepared and revised according to the ARRIVE guidelines.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Wen-Bo Meng, MD, PhD, Doctor, Professor, Department of General Surgery, The First Hospital of Lanzhou University and Laboratory of Biological Therapy and Regenerative Medicine Transformation Gansu Province, No. 1 Donggang West Road, Chengguan District, Lanzhou 730000, Gansu Province, China. mengwb@lzu.edu.cn
Received: August 3, 2023
Peer-review started: August 3, 2023
First decision: September 18, 2023
Revised: September 20, 2023
Accepted: October 11, 2023
Article in press: October 11, 2023
Published online: November 7, 2023
Processing time: 93 Days and 17.3 Hours
Peer-review started: August 3, 2023
First decision: September 18, 2023
Revised: September 20, 2023
Accepted: October 11, 2023
Article in press: October 11, 2023
Published online: November 7, 2023
Processing time: 93 Days and 17.3 Hours
ARTICLE HIGHLIGHTS
Research background
Cholangiocarcinoma sarcoma is a rare tumor composed of epithelial and mesenchymal cells, and the sarcomatous component in carcinosarcoma is differentiated from spindle cells or pleomorphic cells.
Research motivation
There is no extrahepatic cholangiocarcinoma sarcoma cell line.
Research objectives
To establish and characterize a new extrahepatic cholangiocarcinoma sarcoma cell line.
Research methods
Establish cell lines through primary culture and subculture, and identify their biological characteristics.
Research results
In this study, we successfully established and characterized of a extrahepatic cholangiocarcinoma sarcoma cell line CBC2T-2, from the primary tumor of a patient with cholangiocarcinoma sarcoma.
Research conclusions
To date, first report of the extrahepatic cholangiocarcinoma sarcoma cell line CBC2T-2.
Research perspectives
The establishment of extrahepatic cholangiocarcinoma sarcoma cell line provides suitable experimental models for further study of cholangiocarcinoma sarcoma.